These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1677132)

  • 1. Motoneuron-disease-like disorder after ganglioside therapy.
    Scarlato G; Nobile-Orazio E
    Lancet; 1991 Aug; 338(8762):314-5. PubMed ID: 1677132
    [No Abstract]   [Full Text] [Related]  

  • 2. Motoneuron-disease-like disorder after ganglioside therapy.
    Yuki N; Sato S; Miyatake T; Sugiyama K; Katagiri T; Sasaki H
    Lancet; 1991 May; 337(8749):1109-10. PubMed ID: 1673540
    [No Abstract]   [Full Text] [Related]  

  • 3. Guillain-Barré syndrome and parenteral gangliosides.
    Lancet; 1991 Sep; 338(8769):757. PubMed ID: 1679886
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute axonal Guillain-Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides.
    Illa I; Ortiz N; Gallard E; Juarez C; Grau JM; Dalakas MC
    Ann Neurol; 1995 Aug; 38(2):218-24. PubMed ID: 7654069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gangliosides and Guillain-Barré syndrome: the Spanish data.
    Díez-Tejedor E; Gutiérrez-Rivas E; Gil-Peralta A
    Neuroepidemiology; 1993; 12(5):251-6. PubMed ID: 8309499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gangliosides and the Guillain-Barré syndrome].
    Berciano J
    Med Clin (Barc); 1993 Dec; 101(19):758-9. PubMed ID: 8289527
    [No Abstract]   [Full Text] [Related]  

  • 7. Patterns of serum IgM antibodies to GM1 and GD1a gangliosides in amyotrophic lateral sclerosis.
    Pestronk A; Adams RN; Cornblath D; Kuncl RW; Drachman DB; Clawson L
    Ann Neurol; 1989 Jan; 25(1):98-102. PubMed ID: 2913936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are anti-ganglioside antibodies of clinical value in multifocal motor neuropathy?
    Gooch CL; Amato AA
    Neurology; 2010 Nov; 75(22):1950-1. PubMed ID: 20962289
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-ganglioside antibodies in amyotrophic lateral sclerosis revisited.
    Kollewe K; Wurster U; Sinzenich T; Körner S; Dengler R; Mohammadi B; Petri S
    PLoS One; 2015; 10(4):e0125339. PubMed ID: 25875836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exposure to exogenous gangliosides and Guillain-Barré syndrome.
    Beghi E
    Neuroepidemiology; 1995; 14(2):45-8. PubMed ID: 7891813
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical signs of amyotrophic lateral sclerosis developing after polyradiculoneuropathy associated with amitriptyline.
    Leys D; Petit H
    BMJ; 1990 Mar; 300(6724):614. PubMed ID: 2108779
    [No Abstract]   [Full Text] [Related]  

  • 12. A double-blind, placebo-controlled trial of high doses of gangliosides in amyotrophic lateral sclerosis.
    Lacomblez L; Bouche P; Bensimon G; Meininger V
    Neurology; 1989 Dec; 39(12):1635-7. PubMed ID: 2685660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fas small interfering RNA reduces motoneuron death in amyotrophic lateral sclerosis mice.
    Locatelli F; Corti S; Papadimitriou D; Fortunato F; Del Bo R; Donadoni C; Nizzardo M; Nardini M; Salani S; Ghezzi S; Strazzer S; Bresolin N; Comi GP
    Ann Neurol; 2007 Jul; 62(1):81-92. PubMed ID: 17503505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A first total synthesis of a hybrid-type ganglioside associated with amyotrophic lateral sclerosis-like disorder.
    Nakashima S; Ando H; Imamura A; Yuki N; Ishida H; Kiso M
    Chemistry; 2011 Jan; 17(2):588-97. PubMed ID: 21207577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower motor neuron syndrome associated with IgG anti-GM1 antibodies revisited.
    Yuki N; Yanaka C; Sudo M; Funakoshi M; Ishida H; Mori M; Kanda F; Hirata K
    J Neuroimmunol; 2014 Jul; 272(1-2):62-6. PubMed ID: 24841627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Campylobacter infections, Guillain-Barré syndrome, and parenteral gangliosides.
    Callegaro L; Jack DB; Samson JC
    Lancet; 1991 Mar; 337(8744):789. PubMed ID: 1672406
    [No Abstract]   [Full Text] [Related]  

  • 17. Amyotrophic lateral sclerosis with IgM antibody against gangliosides GM2 and GD2.
    Mizutani K; Oka N; Kusunoki S; Kaji R; Kanda M; Akiguchi I; Shibasaki H
    Intern Med; 2003 Mar; 42(3):277-80. PubMed ID: 12705795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exogenous gangliosides and Guillain-Barré syndrome. An observational study in the local health district of Ferrara, Italy.
    Govoni V; Granieri E; Tola MR; Paolino E; Casetta I; Fainardi E; Monetti VC
    Brain; 1997 Jul; 120 ( Pt 7)():1123-30. PubMed ID: 9236625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Multifocal motor neuropathy after administration of gangliosides].
    García-Moncó JC; Gómez Beldarrain M; Ayani I; Estrade L
    Med Clin (Barc); 1992 Sep; 99(9):345-6. PubMed ID: 1435005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guillain-Barré syndrome and ganglioside therapy in Italy.
    Raschetti R; Maggini M; Popoli P
    Lancet; 1992 Jul; 340(8810):60. PubMed ID: 1351644
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.